LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $9,492,218
Key CONT_AWD_75N91020F00014_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 15 days before this system saw it. One version on record.
Cite this row
On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91020F00014_7529_75N91019D00024_7529
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:55:06Z
Content hash
e68ae0d67d85d2ddd18c4ed3d0d634b9de281647d9c916f86814bddbaac6e26cThe source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $9,492,218 | first version | June 30, 2020 | August 21, 2026 | 2026-09-05T00:55:06Z | historical sweep | e68ae0d67d85 |
Archived copy
https://web.archive.org/web/20261013034044/https://www.usaspending.gov/award/CONT_AWD_75N91020F00014_7529_75N91019D00024_7529 captured by this system, October 13, 2026
What the amount is made of
13 recorded actions, so the amount is the award's current total across all of them. 2 of them obligated money. Measured 2026-10-11, when USAspending reported a total obligation of $9,492,218.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| August 21, 2026 | P00012 | OTHER ADMINISTRATIVE ACTION | −$40,507,782 | EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| April 24, 2025 | P00011 | TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL) | no money | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| May 30, 2024 | P00010 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| April 21, 2022 | P00009 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| October 27, 2021 | P00008 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| July 28, 2021 | P00007 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| April 30, 2021 | P00006 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| March 30, 2021 | P00005 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| January 25, 2021 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| November 23, 2020 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| September 1, 2020 | P00002 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| July 8, 2020 | P00001 | OTHER ADMINISTRATIVE ACTION | no money | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
| June 30, 2020 | base | not on file | +$50,000,000 | COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA |
Last refreshed November 4, 2026 at 2:31 PM UTC.